Discovery of novel phenamacril-diphenyl ether hybrids as antifungal leads with a low-toxicity profile.
This research provides novel insights for the development of highly active and low-toxic phenamacril derivatives, and lays the foundation for achieving a closed-loop research and development process involving structure-activity relationships, toxicity prediction, iterative optimization, and re-evaluation.